CRISPR is one of the most revolutionary technologies of the modern era, and now it's being used to bring back long-lost genes ...

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

In a recent study posted to the Journal of Biochemical and Molecular Toxicology, researchers reviewed clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostics for detecting ...

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite the genetic code that condemns someone to a lifetime of suffering.No more ...

The game’s afoot for CRISPR diagnostic developer Sherlock Biosciences. The company hopes to speed up its path to market through the acquisition of the rapid test maker Sense Biodetection. Based in ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate ...

Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...

Researchers have developed a fast, specific and reliable test for mpox infection, combining CRISPR/Cas12a and nanopore sensing. Research presented at the 68th Biophysical Society Annual Meeting (10-14 ...

Preeminent IP position gives Sherlock freedom to operate and commercialize across multiple CRISPR business avenues WATERTOWN, Mass., Feb. 21, 2023 /PRNewswire/ -- Sherlock Biosciences, a company ...